StockData
BioAge Labs, Inc. logo

BioAge Labs, Inc. (BIOA) stock

BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$5.10−0.12 (-2.30%)

Close on Nov 17, 2026Market cap $234.07MP/E –Yield –

BioAge Labs price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

BioAge Labs's price to book ratio was 0.7× on Nov 11, 2026, against 1.2× a year earlier. Over the last 2 years it ranged from 0.4× to 3.1×, with a median of 0.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×−1.0
2025Dec 31, 20251.7×+1.1
2024Dec 31, 20240.6×–

More BioAge Labs figures

See a number that looks wrong?